Adopting the data mining approach, Cui et al. [34] showed that DNA methylation is a factor that contributes to decreased MEG3 expression in breast cancer samples, and the positive correlation between the MEG3 expression and the estrogen receptor (ER) and the progesterone receptor (PR) status were noted. This evidence concerns the gene MEG3 and breast carcinoma.